<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>25454597</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>García-García-de-Paredes, Ana</dc:author>
<dc:author>López-Sanromán, Antonio</dc:author>
<dc:author>Ferre-Aracil, Carlos</dc:author>
<dc:author>Rodríguez-de-Santiago, Enrique</dc:author>
<dc:author>Aguilera-Castro, Lara</dc:author>
<dc:description xml:lang="en">Bacteria can no longer be seen as an enemy. Nowadays, there is enough evidence to place the microbiota as a key element in human homeostasis. Despite initial skepticism, fecal microbiota transplantation (FMT) is a real therapeutic alternative for patients with recurrent Clostridium difficile infection. Moreover, this procedure has shown promising results in ulcerative colitis and other non-gastrointestinal disorders. There is still a lack of knowledge and clinical trials with long- term follow-up. Therefore, the available data should be interpreted with caution. In this document we provide a detailed review of the literature on the intestinal microbiota and FMT.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Inflammatory bowel disease</dc:subject>
<dc:subject>Trasplante de microbiota fecal</dc:subject>
<dc:subject>Fecal microbiota transplantation</dc:subject>
<dc:subject>Clostridium difficile</dc:subject>
<dc:subject>Enfermedad inflamatoria intestinal</dc:subject>
<dc:date>2015 Mar </dc:date>
<dc:title xml:lang="es">Trasplante de microbiota fecal.</dc:title>
<dc:title xml:lang="en">[Fecal microbiota transplantation].</dc:title>
<dc:publisher>Gastroenterologia y hepatologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
